|
DNAJB4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.14859999289507E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.77790046310633E-11 |
| Normal-vs-Stage2 |
7.342500E-03 |
| Normal-vs-Stage3 |
7.476200E-02 |
| Normal-vs-Stage4 |
6.613600E-01 |
| Stage1-vs-Stage2 |
2.085800E-01 |
| Stage1-vs-Stage3 |
1.586010E-01 |
| Stage1-vs-Stage4 |
8.436900E-03 |
| Stage2-vs-Stage3 |
6.975200E-01 |
| Stage2-vs-Stage4 |
2.236200E-01 |
| Stage3-vs-Stage4 |
4.836400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.30249999464161E-09 |
| Normal-vs-AfricanAmerican |
1.14330001022012E-09 |
| Normal-vs-Asian |
9.563600E-01 |
| Caucasian-vs-AfricanAmerican |
1.984420E-01 |
| Caucasian-vs-Asian |
7.189500E-02 |
| AfricanAmerican-vs-Asian |
1.351590E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.87449952729446E-10 |
| Normal-vs-Female |
1.79933999999715E-05 |
| Male-vs-Female |
1.179550E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.58259999999811E-05 |
| Normal-vs-Extreme_Weight |
1.08550000099683E-08 |
| Normal-vs-Obese |
4.71440000371359E-08 |
| Normal-vs-Extreme_Obese |
6.872000E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.949800E-01 |
| Normal_Weight-vs-Obese |
7.135400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.330200E-01 |
| Extreme_Weight-vs-Obese |
8.432200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.927000E-01 |
| Obese-vs-Extreme_Obese |
7.476000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.239830E-01 |
| Normal-vs-Age(41-60Yrs) |
1.477000000083E-08 |
| Normal-vs-Age(61-80Yrs) |
2.05380001894184E-09 |
| Normal-vs-Age(81-100Yrs) |
5.28529999987981E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.006000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.629630E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.073410E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.571800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.735380E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.275000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.79210013285092E-11 |
| Normal-VS-Type2 PRCC |
4.15409999998673E-06 |
| Normal-VS-KIRP CIMP |
5.191600E-01 |
| Normal-VS-Unclassified PRCC |
1.024070E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.487200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.825620E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.073240E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.603840E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.465000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.148400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.23829999998382E-06 |
| Normal-vs-N1 |
5.054200E-01 |
| Normal-vs-N2 |
6.708200E-02 |
| N0-vs-N1 |
6.064000E-02 |
| N0-vs-N2 |
5.722400E-01 |
| N1-vs-N2 |
6.361000E-01 |
|
|
